Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial
Open Access
- 11 September 2019
- journal article
- research article
- Published by Taylor & Francis Ltd in Current Medical Research and Opinion
- Vol. 35 (12), 2097-2102
- https://doi.org/10.1080/03007995.2019.1656955
Abstract
Objective: To evaluate, post hoc, the efficacy and safety of abaloparatide by degree of renal impairment. Methods: ACTIVE was a phase 3, 18-month, randomized, double-blind, active-comparator, placebo-controlled study of postmenopausal women with osteoporosis who received subcutaneous abaloparatide 80 µg, placebo, or open-label teriparatide 20 µg daily. Patients with serum creatinine >2.0 mg/dL or 1.5–2.0 mg/dL with an estimated glomerular filtration rate (eGFR) p = .008) and in the overall ACTIVE safety population (3.4% versus 6.4%; p = .006). Computed tomography scans in 376 patients revealed no evidence of increased renal calcification. Conclusion: Increased exposure to abaloparatide and teriparatide in patients with renal impairment led to no meaningful differences in efficacy or safety. These results support the use of abaloparatide without dosage adjustment in patients with renal impairment, provided those with severe renal impairments are monitored for adverse events.Keywords
This publication has 12 references indexed in Scilit:
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With OsteoporosisJAMA, 2016
- Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream SignalingEndocrinology, 2016
- Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with OsteoporosisJournal of Clinical Endocrinology & Metabolism, 2015
- The Aging Kidney: Physiological ChangesAdvances in Chronic Kidney Disease, 2010
- Molecular and cellular mechanisms of the anabolic effect of intermittent PTHBone, 2007
- Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairmentOsteoporosis International, 2006
- Relationship between age, renal function and bone mineral density in the US populationOsteoporosis International, 2003
- Epidemiology and outcomes of osteoporotic fracturesThe Lancet, 2002
- ForewordAmerican Journal of Kidney Diseases, 2002
- Leptin and renal diseaseAmerican Journal of Kidney Diseases, 2002